Clinical Trials Browser

Phase 2 × Completed × Biological Products × Clear all

NCT04436133 2022-05-06

Immunogenicity AND Safety Study of the 11 Valent Recombinant Human Papillomavirus Vaccine (Hansenulapolymorpha)

Phase 2 Completed

Papillomavirus Infections